Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2

BACKGROUND: Diabetic cardiomyopathy (DCM) is a cardiac complication of long-term uncontrolled diabetes and is characterized by myocardial fibrosis and abnormal cardiac function. Mesenchymal stem cells (MSCs) are multipotent cells with immunoregulatory and secretory functions in diabetes and heart di...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Liyuan, Zhang, Jinying, Deng, Zihui, Liu, Jiejie, Han, Weidong, Chen, Guanghui, Si, Yiling, Ye, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079514/
https://www.ncbi.nlm.nih.gov/pubmed/32183879
http://dx.doi.org/10.1186/s13287-020-01633-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7079514/
https://www.ncbi.nlm.nih.gov/pubmed/32183879
http://dx.doi.org/10.1186/s13287-020-01633-7

Ejemplares similares